Employees: 195
Size Jenscare Scientific (9877.HK) is a Hong Kong Health Care company (Medical Specialties) with a market value of $415M, the 792nd largest of 885 Hong Kong companies the cockpit tracks. Shares closed at HK$5.76 on 18 Nov 2026.
Performance Over six months the shares fell 32.2%, against -19.4% for the median peer and -14.0% for the Hong Kong market (cap-weighted) — 5th lowest of 21 in its peer set.
Growth Revenue grew 992.7% over the last twelve months (peer median +7.3%); the operating margin is -106.3% (peer median 8.1%).
Valuation It trades at 17.8× enterprise value to sales against a peer median of 3.9× (most expensive of 19).
Capital Return on invested capital runs 43.4 points below its cost of capital (8.1% WACC).
Next results Next results expected around 31 Mar 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | HK$158M | HK$98.2M | HK$0 | HK$0 | HK$0 |
| Revenue growth | — | — | — | — | — |
| Gross profit | HK$121M | HK$74.6M | -HK$13.9M | -HK$13.3M | -HK$10.7M |
| EBITDA | -HK$147M | -HK$242M | -HK$222M | -HK$471M | -HK$584M |
| Net income | -HK$167M | -HK$294M | -HK$192M | -HK$411M | -HK$511M |
| Free cash flow | -HK$84.6M | -HK$86.2M | -HK$313M | -HK$332M | -HK$247M |
| Capital expenditure | HK$17.6M | HK$5.50M | HK$77.7M | HK$86.9M | HK$57.6M |
| Total debt | n/a | HK$52.8M | HK$68.6M | HK$48.5M | HK$4.35M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 9877.HK | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -16.5% | -10.5% | 3rd lowest of 21 |
| 6-month return | -32.2% | -19.4% | 5th lowest of 21 |
| Distance from 52-week high | -45.2% | -36.0% | 9th lowest of 21 |
| Revenue growth (TTM) | +992.7% | +7.3% | highest of 20 |
| Operating margin | -106.3% | 8.1% | 2nd lowest of 20 |
| EV / Sales | 17.8× | 3.9× | most expensive of 19 |
| ROIC minus cost of capital | -43.4 pp | -2.1 pp | 2nd lowest of 18 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | EV / Sales | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Jenscare Scientific 9877.HK | Hong Kong | $415M | -32% | +993% | -106% | 17.8× | n/a | n/a |
| Ningbo Tianyi Medical Appliance 301097.SZ | China | $418M | -22% | +46% | 8% | 4.4× | n/a | n/a |
| Chison Medical Technologies 688358.SS | China | $406M | -27% | -1% | 19% | 3.9× | 9.6% | +5.6% |
| Hunan Sundy Science and Technology 300515.SZ | China | $425M | -16% | +10% | 27% | 3.5× | -0.1% | +15.6% |
| Shanghai Titan Scientific 688133.SS | China | $403M | -26% | +1% | -6% | 1.4× | n/a | n/a |
| China Isotope & Radiation 1763.HK | Hong Kong | $428M | -41% | -5% | 13% | n/a | n/a | n/a |
| Revenio REG1V.HE | Finland | $428M | -34% | +44% | 10% | 4.0× | 18.5% | +12.4% |
| Shoulder Innovations SI | United States | $432M | +39% | +55% | -54% | 5.5× | n/a | n/a |
| Guanhao Biotech 300238.SZ | China | $397M | -26% | -12% | 3% | 7.1× | n/a | n/a |
| Mobia Medical MOBI | United States | $434M | +2% | +105% | -145% | 8.8× | n/a | n/a |
| 908 Devices MASS | United States | $396M | +36% | +14% | -33% | 4.6× | 41.7% | +15.9% |
| Guangzhou Jet Bio-Filtration 688026.SS | China | $436M | +39% | +5% | 11% | 4.8× | 20.6% | +2.2% |
| OrbusNeich Medical 6929.HK | Hong Kong | $394M | -15% | +16% | 23% | 1.0× | -17.6% | +15.4% |
| SEERS 458870.KS | South Korea | $392M | -70% | +174% | 37% | 5.5× | -6.3% | +247.0% |
| Huaren Pharmaceutical 300110.SZ | China | $440M | -16% | -3% | 6% | 3.3× | 5.8% | +0.3% |
| Cerus CERS | United States | $392M | -28% | +14% | -12% | 1.8× | n/a | n/a |
| Shanghai Kehua Bio-Engineering 002022.SZ | China | $389M | -14% | +7% | -40% | 1.7× | n/a | n/a |
| Clarity Pharmaceuticals CU6.AX | Australia | $444M | -33% | n/a | n/a | n/a | n/a | n/a |
| Taidoc Technology 4736.TW | Taiwan | $387M | 0% | 0% | 19% | 1.8× | -9.5% | -6.6% |
| Shanghai Kindly Enterprises Development 603987.SS | China | $452M | -12% | 0% | 10% | 1.5× | -1.0% | -2.8% |
| Guangdong Shirongzhaoye 002016.SZ | China | $453M | -26% | -31% | 3% | 3.8× | 21.5% | -11.7% |